Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: In vitro and in vivo

This publication has 33 references indexed in Scilit:

• RETRACTED: PEGylation enhances tumor targeting of plasmid DNA by an artificial cationized protein with repeated RGD sequences, Pronectin®
  Journal of Controlled Release, 2004
• Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer
  The Journal of Gene Medicine, 2003
• Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution study
  International Journal of Cancer, 2002
• Tumor Regression by Targeted Gene Delivery to the Neovasculature
  Science, 2002
• Potential tumor-targeting peptide vector of histidylated oligolysine conjugated to a tumor-homing RGD motif
  Cancer Gene Therapy, 2001
• αv Integrins as receptors for tumor targeting by circulating ligands
  Nature Biotechnology, 1997
• Ligation of Integrin α5β1 Is Required for Internalization of Vitronectin by Integrin αvβ3
  Published by Elsevier ,1997
• Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cells
  European Journal Of Cancer, 1995
• Binding and internalization of microorganisms by integrin receptors
  Trends in Microbiology, 1994
• Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis
  Nature, 1990